Please Note:
This profile was automatically generated using 2 references found on the Internet. This information has not been verified. Learn more...
This profile was automatically generated using 2 references found on the Internet. This information has not been verified. Learn more...
Web References
-
1. Spotlight on the WHO regions
www.whomsa.ehost.com/it/text11 - [Cached]Published on: 12/22/2005 Last Visited: 12/22/2005
In his opening remarks on behalf of the WHO Regional Director for Africa, Dr M. Belhocine, Director, Division of Noncommunicable Diseases, WHO Regional Office for Africa, pointed out that only 10 of the 46 countries in the Region had embarked on Global Campaign activities, most of them led by NGOs and associations with little support from national health authorities. Paricipants therefore needed to help sensitize decision-makers, so that they understood the core message: that epilepsy is a public health concern in Africa; that most causes of epilepsy are preventable; that epilepsy can be treated; and that people living with epilepsy can enjoy better lives and contribute further to social and economic development. Dr Belhocine also referred to the important role of Senegal and Zimbabwe as the site of demonstration projects designed to develop good practices and reduce the treatment gap in the Region. -
2. Spotlight on the WHO regions
www.whomsa.org/it/text11/04_sp - [Cached]Published on: 5/7/2004 Last Visited: 5/7/2004
In his opening remarks on behalf of the WHO Regional Director for Africa, Dr M. Belhocine, Director, Division of Noncommunicable Diseases, WHO Regional Office for Africa, pointed out that only 10 of the 46 countries in the Region had embarked on Global Campaign activities, most of them led by NGOs and associations with little support from national health authorities. Paricipants therefore needed to help sensitize decision-makers, so that they understood the core message: that epilepsy is a public health concern in Africa; that most causes of epilepsy are preventable; that epilepsy can be treated; and that people living with epilepsy can enjoy better lives and contribute further to social and economic development. Dr Belhocine also referred to the important role of Senegal and Zimbabwe as the site of demonstration projects designed to develop good practices and reduce the treatment gap in the Region.
